Get started
IONIS PHARMACEUTICALS INC COM USD0.001IONIS PHARMACEUTICALS INC COM USD0.001IONIS PHARMACEUTICALS INC COM USD0.001

IONIS PHARMACEUTICALS INC COM USD0.001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

0JDI chart


Full chart

0JDI upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.72 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.0 USD
Net income (FY)
‪−453.90 M‬ USD
Revenue (FY)
‪705.14 M‬ USD
Shares float
‪154.57 M‬
Beta (1Y)
0.65

Employees


Employees (FY)
‪1.07 K‬
Change (1Y)
+142 +15.32%
Revenue / Employee (1Y)
‪659.62 K‬ USD
Net income / Employee (1Y)
‪−424.60 K‬ USD

About Ionis Pharmaceuticals, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Brett P. Monia
Website
ionis.com
Headquarters
Carlsbad
Founded
1989
FIGI
BBG00JVRNSN2
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0JDI news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

0JDI highest yielding bonds


IONS5835891
Ionis Pharmaceuticals, Inc. 1.75% 15-JUN-2028
Yield to maturity
3.14%
Maturity date
Jun 15, 2028
IONS5397611
Ionis Pharmaceuticals, Inc. 0.0% 01-APR-2026
Yield to maturity
2.40%
Maturity date
Apr 1, 2026

See all 0JDI bonds 


Check out other big names from the same industry as 0JDI.

Frequently Asked Questions


The current price of 0JDI is 29.7 USD — it has increased by 1.06% in the past 24 hours. Watch IONIS PHARMACEUTICALS INC COM USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange IONIS PHARMACEUTICALS INC COM USD0.001 stocks are traded under the ticker 0JDI.
0JDI stock has risen by 5.10% compared to the previous week, the month change is a −6.17% fall, over the last year IONIS PHARMACEUTICALS INC COM USD0.001 has showed a −29.17% decrease.
We've gathered analysts' opinions on IONIS PHARMACEUTICALS INC COM USD0.001 future price: according to them, 0JDI price has a max estimate of 78.00 USD and a min estimate of 37.00 USD. Watch 0JDI chart and read a more detailed IONIS PHARMACEUTICALS INC COM USD0.001 stock forecast: see what analysts think of IONIS PHARMACEUTICALS INC COM USD0.001 and suggest that you do with its stocks.
0JDI reached its all-time high on Apr 4, 2019 with the price of 84.3 USD, and its all-time low was 24.6 USD and was reached on Apr 9, 2025. View more price dynamics on 0JDI chart.
See other stocks reaching their highest and lowest prices.
0JDI stock is 2.92% volatile and has beta coefficient of 0.65. Track IONIS PHARMACEUTICALS INC COM USD0.001 stock price on the chart and check out the list of the most volatile stocks — is IONIS PHARMACEUTICALS INC COM USD0.001 there?
Today IONIS PHARMACEUTICALS INC COM USD0.001 has the market capitalization of ‪4.72 B‬, it has increased by 1.79% over the last week.
Yes, you can track IONIS PHARMACEUTICALS INC COM USD0.001 financials in yearly and quarterly reports right on TradingView.
IONIS PHARMACEUTICALS INC COM USD0.001 is going to release the next earnings report on Apr 30, 2025. Keep track of upcoming events with our Earnings Calendar.
0JDI earnings for the last quarter are −0.66 USD per share, whereas the estimation was −1.12 USD resulting in a 41.29% surprise. The estimated earnings for the next quarter are −1.10 USD per share. See more details about IONIS PHARMACEUTICALS INC COM USD0.001 earnings.
IONIS PHARMACEUTICALS INC COM USD0.001 revenue for the last quarter amounts to ‪227.00 M‬ USD, despite the estimated figure of ‪135.33 M‬ USD. In the next quarter, revenue is expected to reach ‪131.39 M‬ USD.
0JDI net income for the last quarter is ‪−104.00 M‬ USD, while the quarter before that showed ‪−140.48 M‬ USD of net income which accounts for 25.97% change. Track more IONIS PHARMACEUTICALS INC COM USD0.001 financial stats to get the full picture.
No, 0JDI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 27, 2025, the company has ‪1.07 K‬ employees. See our rating of the largest employees — is IONIS PHARMACEUTICALS INC COM USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IONIS PHARMACEUTICALS INC COM USD0.001 EBITDA is ‪−452.27 M‬ USD, and current EBITDA margin is −64.26%. See more stats in IONIS PHARMACEUTICALS INC COM USD0.001 financial statements.
Like other stocks, 0JDI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IONIS PHARMACEUTICALS INC COM USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IONIS PHARMACEUTICALS INC COM USD0.001 technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IONIS PHARMACEUTICALS INC COM USD0.001 stock shows the sell signal. See more of IONIS PHARMACEUTICALS INC COM USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.